Filters








10,826 Hits in 4.5 sec

Revealing the cosmic reionisation history with fast radio bursts in the era of Square Kilometre Array [article]

Tetsuya Hashimoto, Tomotsugu Goto, Ting-Yi Lu, Alvina Y. L. On, Daryl Joe D. Santos, Seong Jin Kim, Ece Kilerci Eser, Simon C.-C. Ho, Tiger Y.-Y. Hsiao, Leo Y.-W. Lin
2021 arXiv   pre-print
We considered three cases of redshift measurements: (A) spectroscopic redshift for all mock data, (B) spectroscopic redshift for 10 mock data, and (C) redshift estimated from an empirical relation of FRBs  ...  (c) The dispersion measure of the intergalactic medium as a function of redshift.  ...  We caution that there are two assumptions behind Mock data C. One is the reduction of dispersion around the relation in the SKA era.  ... 
arXiv:2101.08798v1 fatcat:aruvwtf6tjgolfgs3ourbfouoa

Trends and Outcomes of Proton Radiation Therapy Use for Non–Small Cell Lung Cancer

Amy C. Moreno, Ning Zhang, Sharon H. Giordano, Zhongxing Liao, Daniel Gomez, Joe Y. Chang, Steven H. Lin
2018 International Journal of Particle Therapy  
Lin, MD, PhD, has received research funding from Elekta, STCube Pharmaceuticals, Peregrine, Hitachi Chemical Inc, and Roche/Genentech; has served as consultant for AstraZeneca; and has received honoraria  ...  Characteristic Overall, N ¼ 506 (%) ARF, N ¼ 253 (50%) CCP, N ¼ 253 (50%) P value Age at diagnosis, y Median 70 69 72 .163 Range 42-89 42-89 42-89 Gender Male 270 (53) 131 (52) 139  ... 
doi:10.14338/ijpt/18-00029.1 pmid:31773031 pmcid:PMC6874194 fatcat:otqsnobb4veetjgsigrj3y3wii

The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy

Arya Amini, Arlene M. Correa, Ritsuko Komaki, Joe Y. Chang, Anne S. Tsao, Jack A. Roth, Stephen G. Swisher, David C. Rice, Ara A. Vaporciyan, Steven H. Lin
2012 Annals of Thoracic Surgery  
Fig 1 . 1 Kaplan-Meier curves illustrating (A) cumulative locoregional (LR)-free probability, (B) cumulative distant metastasis (DM)-free recurrence, and (C) cumulative overall survival (OS) with postoperative  ... 
doi:10.1016/j.athoracsur.2012.04.088 pmid:22819472 pmcid:PMC3468148 fatcat:fxputvpccfe2lpdbsdieeidbnu

The Coronary Artery Disease–Reporting and Data System (CAD-RADS)

Joe X. Xie, Ricardo C. Cury, Jonathon Leipsic, Matthew T. Crim, Daniel S. Berman, Heidi Gransar, Matthew J. Budoff, Stephan Achenbach, Bríain Ó Hartaigh, Tracy Q. Callister, Hugo Marques, Ronen Rubinshtein (+22 others)
2018 JACC Cardiovascular Imaging  
C : C A R D I O V A S C U L A R I M A G I N G , V O L . 1 1 , N O . 1 , 2 0 1 8  ...  (4.96-10.45) <0.0001 6.87 (4.85-9.75) <0.0001 CAD-RADS 4B 9.15 (5.58-15.01) <0.0001 9.24 (5.87-14.55) <0.0001 CAD-RADS 5 9.97 (6.23-15.94) <0.0001 9.07 (5.79-14.20) <0.0001 J A C  ... 
doi:10.1016/j.jcmg.2017.08.026 pmid:29301713 fatcat:zag2nfvhajc6xclkqugivvbjtm

Superior Risk Stratification With Coronary Computed Tomography Angiography Using a Comprehensive Atherosclerotic Risk Score

Alexander R. van Rosendael, Leslee J. Shaw, Joe X. Xie, Aukelien C. Dimitriu-Leen, Jeff M. Smit, Arthur J. Scholte, Jacob M. van Werkhoven, Tracy Q. Callister, Augustin DeLago, Daniel S. Berman, Martin Hadamitzky, Jeorg Hausleiter (+25 others)
2019 JACC Cardiovascular Imaging  
The c-index of the training sample (derivation cohort), using a model containing clinical characteristics and the comprehensive CTA score was 0.749; the c-index of the validation sample was 0.789.  ...  In the external validation cohort, the c-index of this model was 0.718 (95% CI: 0.682 to 0.744), significantly higher than the clinical model (0.689, p < 0.001).  ... 
doi:10.1016/j.jcmg.2018.10.024 pmid:30660516 pmcid:PMC6635103 fatcat:f5pb7hgz5ncxjoszwiyiy7ghju

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Xifeng Wu, Yuanqing Ye, Rafael Rosell, Christopher I. Amos, David J. Stewart, Michelle A.T. Hildebrandt, Jack A. Roth, John D. Minna, Jian Gu, Jie Lin, Shama C. Buch, Tomoko Nukui (+10 others)
2011 Journal of the National Cancer Institute  
Overall survival is shown for A) the MD Anderson dis- covery set, B) the Mayo Clinic validation set, and C)the PLATAX validation set.  ...  validation PLATAX validation for rs10937823 PLATAX validation for rs1878022 Total No. of patients 327 315 420 277 Median survival time, mo 12.83 16.28 8.88 8.88 Age, median (range), y  ... 
doi:10.1093/jnci/djr075 pmid:21483023 pmcid:PMC3096796 fatcat:bkajzfwnkvh7vpke6mrvmt6qym

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 5.2018

David S. Ettinger, Dara L. Aisner, Douglas E. Wood, Wallace Akerley, Jessica Bauman, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D'Amico, Thomas J. Dilling, Michael Dobelbower, Ramaswamy Govindan, Matthew A. Gubens (+21 others)
2018 The Journal of the National Comprehensive Cancer Network  
EGFR mutations: Limited mutation-specifi c antibodies are available for EGFR.  ...  BRAF p.V600E mutations: An antibody specifi c to the p.V600E mutation is available.  ... 
doi:10.6004/jnccn.2018.0062 pmid:30006423 fatcat:xl5vjkpjdzaldedfb2tfcuisb4

NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020

David S. Ettinger, Douglas E. Wood, Charu Aggarwal, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D'Amico, Thomas J. Dilling (+25 others)
2019 The Journal of the National Comprehensive Cancer Network  
The NCCN Guidelines for Non–Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates in immunotherapy. For the 2020 update, all of the systemic therapy regimens have been categorized using a new preference stratification system; certain regimens are now recommended as "preferred interventions," whereas others are categorized as either "other recommended interventions" or "useful under certain circumstances."
doi:10.6004/jnccn.2019.0059 pmid:31805526 fatcat:ow2qbdfpijaqzf6ttu6w5rgc2i

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021

David S Ettinger, Douglas E Wood, Dara L Aisner, Wallace Akerley, Jessica R Bauman, Ankit Bharat, Debora S Bruno, Joe Y Chang, Lucian R Chirieac, Thomas A D'Amico, Thomas J Dilling, Jonathan Dowell (+26 others)
2021 The Journal of the National Comprehensive Cancer Network  
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.
doi:10.6004/jnccn.2021.0013 pmid:33668021 fatcat:5beugqwprbbbdiwmegm7stf7pe

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S. Ettinger, Douglas E. Wood, Dara L. Aisner, Wallace Akerley, Jessica R. Bauman, Ankit Bharat, Debora S. Bruno, Joe Y. Chang, Lucian R. Chirieac, Thomas A. D'Amico, Malcolm DeCamp, Thomas J. Dilling (+30 others)
2022 The Journal of the National Comprehensive Cancer Network  
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.
doi:10.6004/jnccn.2022.0025 pmid:35545176 fatcat:xtd5jgnph5hpjbxxz5dp4xde5m

Table of Contents

2021 IEEE/ACM Transactions on Networking  
Wang, Y. Ruan, Y. Tu, S. Wagle, C. G. Brinton, and C. Joe-Wong Toward Optimal Partial Parallelization for Service Function Chaining I-C. Lin, Y.-H. Yeh, and K. C.-J.  ...  Ornee and Y. Sun NB-Cache: Non-Blocking In-Network Caching for High-Performance Content Routers T. Pan, X. Lin, E. Song, C. Xu, J. Zhang, H. Li, J. Lv, T. Huang, B. Liu, and B.  ... 
doi:10.1109/tnet.2021.3111379 fatcat:kwe5hnuuxzhchhuyxmpbvlq32u

2020 Index IEEE Journal of Oceanic Engineering Vol. 45

2020 IEEE Journal of Oceanic Engineering  
Lin, Y., +, JOE Jan. 2020 174-188 Geoacoustic Inversion for a New England Mud Patch Sediment Using the Silt-Suspension Theory of Marine Mud.  ...  Lin, Y., +, JOE Jan. 2020 174-188 Barclay, D.R., +, JOE Jan. 2020 51-59 Evaluation of Alternative Direction-of-Arrival Methods for Oceanographic HF Radars.  ... 
doi:10.1109/joe.2020.3032823 fatcat:wfq6wiyxk5h63mnyepeivwxrlm

Table of contents

2019 IEEE Electron Device Letters  
Joe, C. K. Dabhi, K. Thakor, Y. S. Chauhan, J. Henkel, and S.  ...  -C. Lai, C.-L. Lin, and J.  ... 
doi:10.1109/led.2018.2884102 fatcat:r5l2awurwvcbhg7f4hbk5azlrq

Page 337 of Mechanical Engineering Vol. 32, Issue 2 [page]

1910 Mechanical Engineering  
Dad > ee eo f ~5 ; Sv @ | [ie © +—y + Wd joe ¥ 4 so ac > wa r ' mS IN 10} Arn ifYw is + os c 1G SG 3/ ies Uo & b AS — 3°¢ cl Vv i C \ C .  ...  A , Bid eo % LIN + 3 ; } 3 i « ery >\ oz kat a) ies , GY = —_ “ — - x 5 t poz 92 | 9 you o . < BA +> - — 662¢ Ges TO; t eae IINVa WN ASS i mt wr ' a ¢ » - oe re ¢ eS & + 4 » < ee vv) as ; ° C hy £ « ;  ... 

Yazınsal Metin-Okur Etkileşimi: Altbirimlerin Anlamlandırma Sürecine Etkileri Üzerine Deneysel Bir Çalışma

Semiramis Yağcıoğlu
1998 Dilbilim Araştırmaları Dergisi  
Öyleki, 1950'lerde D u b lin lile r üzerine yazan bir dizi eleştirmen, kitabı oluşturan 15 öyküyü gevşek yapılı ve episodik bulmuşlar ve daha da ileri giderek onları "önemsiz" bulmuşlardır.  ...  Y azılan ikinci ö zet m etin lerd e ise Joe D ıllon adı % 100 o ran ın d a kullanılmadığı saptanmıştır.  ...  M etin ve Onsayıltı Bu deneysel çalışm ada İrlandalI yazar Jam es Jo y ce'un D u b lin lile r öykü kitabından gençlik bölüm ünde yer alan "B ir K arşılaşm a" adlı öyküsünün M urat Belge tarafından yapılan  ... 
doaj:94411a854acc48f08a333c08d04630d3 fatcat:ubgejjhs2nfmjcbenq65etwcvu
« Previous Showing results 1 — 15 out of 10,826 results